Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627).
Times cited: 17
Quantitative method for the determination of iso-fludelone (KOS-1803) in human plasma by LC-MS/MS.
Journal of Pharmaceutical and Biomedical Analysis.
Times cited: 1